Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
Moderna Therapeutics — Wikipédia
PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Moncef Slaoui - Wikipedia
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
